Medmix Ltd
SIX:MEDX
Medmix Ltd
Free Cash Flow
Medmix Ltd
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Medmix Ltd
SIX:MEDX
|
Free Cash Flow
CHf38.1m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Metall Zug AG
SIX:METN
|
Free Cash Flow
-CHf20.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-44%
|
CAGR 10-Years
N/A
|
|
|
Sonova Holding AG
SIX:SOON
|
Free Cash Flow
CHf569.6m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
1%
|
CAGR 10-Years
6%
|
|
|
Medacta Group SA
SIX:MOVE
|
Free Cash Flow
-€7.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Straumann Holding AG
SIX:STMN
|
Free Cash Flow
CHf315.6m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
Medmix Ltd
Glance View
medmix AG designs, develops and produces delivery devices for the mixing, application and injection of liquids for the healthcare, consumer and industrial end-markets. The company is headquartered in Zug, Zug and currently employs 2,101 full-time employees. The firm operates in business areas such as: the dental segment, which provides MIXPAC and transcodent - system solutions that are used to dose, mix and apply various types of dental materials; drug delivery- solutions for the dosage and application of drugs; a surgical segment which provides devices for bone regeneration and tissue healing; an industry segment that specializes in the mixing and dosing of sealants and adhesives through IXPAC , COX and MK; and a beauty segment in which it produces cosmetic applicators through the GEKA brand.
See Also
What is Medmix Ltd's Free Cash Flow?
Free Cash Flow
38.1m
CHF
Based on the financial report for Dec 31, 2024, Medmix Ltd's Free Cash Flow amounts to 38.1m CHF.
What is Medmix Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-6%
Over the last year, the Free Cash Flow growth was 1 091%. The average annual Free Cash Flow growth rates for Medmix Ltd have been -12% over the past three years , -6% over the past five years .
You don't have any saved screeners yet